Alignment Healthcare, Inc. $ALHC Shares Acquired by Danica Pension Livsforsikringsaktieselskab

Danica Pension Livsforsikringsaktieselskab grew its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 25.2% during the first quarter, Holdings Channel reports. The institutional investor owned 2,503,577 shares of the company’s stock after acquiring an additional 503,577 shares during the period. Danica Pension Livsforsikringsaktieselskab’s holdings in Alignment Healthcare were worth $44,113,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in ALHC. Vanguard Group Inc. lifted its stake in shares of Alignment Healthcare by 10.9% in the 4th quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock worth $305,983,000 after acquiring an additional 1,524,218 shares during the period. Wellington Management Group LLP increased its stake in shares of Alignment Healthcare by 26.9% during the fourth quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock valued at $277,900,000 after acquiring an additional 2,981,166 shares during the period. T. Rowe Price Investment Management Inc. increased its stake in shares of Alignment Healthcare by 0.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock valued at $249,715,000 after acquiring an additional 79,268 shares during the period. Invesco Ltd. raised its holdings in Alignment Healthcare by 38.9% during the fourth quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock worth $122,501,000 after purchasing an additional 1,735,962 shares in the last quarter. Finally, 8 Knots Management LLC raised its holdings in Alignment Healthcare by 6.4% during the second quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock worth $70,222,000 after purchasing an additional 300,409 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Trading Up 1.9%

Shares of NASDAQ:ALHC opened at $21.50 on Wednesday. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58. The stock has a market capitalization of $4.44 billion, a price-to-earnings ratio of 238.89, a PEG ratio of 2.85 and a beta of 1.05. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $25.12. The company has a 50 day moving average price of $19.38 and a 200 day moving average price of $19.87.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. The firm had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.Alignment Healthcare’s revenue was up 33.3% on a year-over-year basis. During the same quarter last year, the business posted ($0.05) EPS. On average, research analysts anticipate that Alignment Healthcare, Inc. will post 0.2 EPS for the current fiscal year.

Insider Activity

In other Alignment Healthcare news, insider Mark D. Kent bought 14,848 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was acquired at an average price of $13.31 per share, with a total value of $197,626.88. Following the completion of the transaction, the insider directly owned 14,848 shares in the company, valued at approximately $197,626.88. This represents a ? increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO John E. Kao sold 298,000 shares of Alignment Healthcare stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $20.36, for a total value of $6,067,280.00. Following the transaction, the chief executive officer owned 1,386,766 shares in the company, valued at $28,234,555.76. This represents a 17.69% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 1,039,951 shares of company stock worth $19,976,967. 5.20% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have issued reports on ALHC. Wolfe Research started coverage on Alignment Healthcare in a research note on Friday, April 17th. They set an “outperform” rating and a $24.00 price target for the company. Barclays dropped their price objective on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. UBS Group restated a “neutral” rating on shares of Alignment Healthcare in a report on Wednesday, July 8th. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Finally, Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Six investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $24.30.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.